Ardent Health (ARDT): Fair Value Consensus

Brandmark of Ardent Health Partners Inc (ARDT)

Ardent Health Partners, Inc. (ARDT) is implementing RPA systems to automate insurance settlements and surgical planning. Management is focusing on process digitalization to enhance profitability and operational efficiency, which currently stands at 15.83. This price chart reflects the dynamics of a regional operator that integrates inpatient and outpatient facilities to fully retain patient flow within its local network.

ARDT (Ardent Health Corp) Consensus Target history from 07/19/2024 to 11/11/2026

Metric breakdowns and analytics for Ardent Health Partners Inc (ARDT)

- stock value and consensus price forecast:
General company analysis:ARDT - ardenthealth.com
Brand item of Ardent Health Corp

Investors assess the long-term risks of Ardent Health Partners, Inc. (ARDT) through the lens of professional community expectations. This indicator aggregates average price targets from leading investment houses, capturing the market consensus at the close of each session. By analyzing this analyst consensus chart for the stock, one can identify trends in the revaluation of the business. The dynamics of these forecasts reflect the market's confidence in the efficiency of the company's closed medical ecosystem. The integration of all treatment stages minimizes patient attrition, supporting the fundamental stability of the share price.

Competing companies

Analyst Consensus Forecast hcahealthcare.com (HCA)|Price Target Chart Tenet Healthcare Corporation THC|Fair Value Consensus FMS|Solventum Inc. - Analyst Consensus Forecast|EHC (Encompass) - Broker Consensus Forecast|UHS (uhsinc.com) - Consensus Target|DVA: Analyst Forecast Prices|Consensus Target RDNT|OPCH (Option Care) - Analyst Forecast Prices|Price Target Chart Surgery Partners Corp (SGRY)|PINC (Premier Health) - Fair Value Consensus|Analyst Consensus Forecast EYE (National Vision Holdings)|progyny.com (PGNY) - Average Forecast Price|Select Medical Holdings - Analyst Consensus Forecast|ASTH - Analyst Consensus Forecast|MD (Pediatrix Medical Group) - Consensus Target|USPH: Analyst Forecast Prices|Price Target Chart The Pennant Group, Inc.|Consensus Target organogenesis.com (ORGO)|Analyst Consensus Forecast NUTX|AUNA - Average Forecast Price|Price Target Chart sbc-holdings.com SBC|EOLS: Broker Consensus Forecast|CYH: Consensus Target|The Beauty Health - Analyst Forecast Prices|MDWD: Analyst Consensus Forecast|Biote (BTMD) - Analyst Consensus Forecast|Price Target Chart The Joint Corporation|DCGO: Fair Value Consensus|Analyst Consensus Forecast PIII|Gain Therapeutics Inc. - Broker Consensus Forecast|Analyst Consensus Forecast EUDA (EUDA Health)|Basel Medical (BMGL) - Average Forecast Price|CLGN - Price Target Chart|CUPR (Cuprina Holdings Limited) - Broker Consensus Forecast|CCM (Concord Medical Services) - Consensus Target|AMS: Analyst Forecast Prices|Consensus Target MRM|ALBT: Fair Value Consensus|Analyst Consensus Forecast DHAI|XAGE (Carmell Corp) - Fair Value Consensus|Analyst Consensus Forecast NIVF (NewGenIvf Group Limited)|ATI Physical Therapy Inc. (ATIP) - Average Forecast Price|CareMax - Analyst Consensus Forecast|KDLY - Analyst Consensus Forecast|LogistiCare (MODV) - Price Target Chart|NVOS (Novo Integrated Sciences Corp) - Price Target Chart|Consensus Target SSY|BACK (imacholdings.comm) - Analyst Forecast Prices